RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
74 hedge funds and large institutions have $1.01B invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 34 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
74
Holders Change
+23
Holders Change %
+45.1%
% of All Funds
1.14%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
27
Increased
34
Reduced
5
Closed
4
Calls
$7.38M
Puts
$67K
Net Calls
+$7.31M
Net Calls Change
+$7.31M
Top Buyers
1 |
1
BlackRock
New York
|
$85.4M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$47.2M |
3 |
3
State Street
Boston,
Massachusetts
|
$17.5M |
4 |
4
Norges Bank
Oslo,
Norway
|
$23.9M |
5 |
FAM
5
Fred Alger Management
New York
|
$6.82M |